Skip to main content
$0.26 $0.00 (1.7%)

04:00 PM EDT on 05/20/22

Statera BioPharma, Inc. (NASDAQ:STAB)

CAPS Rating: No stars

Cytocom, Inc., a clinical-stage biopharmaceutical company, develops novel small molecule immunotherapies targeting cancer, autoimmune, inflammatory, and infectious diseases. Its platform, Advanced Immunomodulating Multi-receptor System (AIMS), offers noroxymorphone analogs multi-receptor modulating therapies and proenkephalin analogs multi-receptor modulating therapies.

Current Price $0.26 Mkt Cap $12.9M
Open $0.26 P/E Ratio 0.00
Prev. Close $0.26 Div. (Yield) $0.00 (0.0%)
Daily Range $0.24 - $0.26 Volume 718,444
52-Wk Range $0.20 - $7.10 Avg. Daily Vol. 11,071,753

Caps

How do you think NASDAQ:STAB will perform against the market?

Add Stock to CAPS Watchlist

All Players

82 Outperform
12 Underperform
 

All-Star Players

6 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:STAB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LifeScientist (52.23)
Submitted July 16, 2020

Good entry point, short term technicals

NetscribeServcs (< 20)
Submitted March 21, 2007

Cleveland Biolabs (CBL) is a biotechnology research and development company, which develops drugs offering protection from radiation and cancer. CBL is engaged in the development of small molecule drugs and biologics focusing on two therapeutic… More

Recent Community Commentary

Read the most recent pitches from players about STAB.

Recs

1
Member Avatar LifeScientist (52.23) Submitted: 7/16/2020 9:51:12 AM : Outperform Start Price: $2.91 NASDAQ:STAB Score: -111.68

Good entry point, short term technicals

Recs

0
Member Avatar turningpoint84 (71.16) Submitted: 7/22/2013 12:00:53 PM : Outperform Start Price: $33.34 NASDAQ:STAB Score: -228.03

I have a good feeling about them.

Recs

0
Member Avatar JULGABANN (< 20) Submitted: 4/9/2013 5:45:23 PM : Outperform Start Price: $32.00 NASDAQ:STAB Score: -254.54

Cleveland is way undervalued at this point, 2 drug applications for CBLB502 and a BARDA deal on the way... this will double in weeks and be a great buy and hold stock for years to come.

Leaderboard

Find the members with the highest scoring picks in STAB.

Score Leader

longtermgrowth09

longtermgrowth09 (50.79) Score: +344.49

The Score Leader is the player with the highest score across all their picks in STAB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
longtermgrowth09 50.79 8/3/2010 Underperform 5Y $74.80 -99.66% +244.83% +344.49 0 Comment
Okcfirefighter < 20 12/17/2010 Underperform 5Y $139.20 -99.82% +211.81% +311.63 0 Comment
thecashmen 23.09 6/5/2012 Underperform 5Y $41.40 -99.38% +203.38% +302.75 1 Comment
jarhead6266 67.50 3/19/2007 Underperform NS $169.40 -99.85% +194.21% +294.05 0 Comment
NetscribeServcs < 20 3/21/2007 Underperform 1Y $178.00 -99.86% +190.60% +290.46 1 Comment
BreakerDc 80.35 3/21/2007 Underperform 3Y $178.20 -99.86% +186.02% +285.88 0 Comment
BetterMoney77 < 20 1/2/2008 Underperform NS $175.80 -99.85% +175.85% +275.71 0 Comment
BigWhereItCounts < 20 7/16/2007 Underperform 3Y $220.00 -99.88% +163.44% +263.32 1 Comment
badpiotroski < 20 6/26/2013 Underperform 5Y $30.60 -99.16% +142.89% +242.05 0 Comment
helicopterfool 91.37 6/25/2015 Underperform 5Y $6.55 -96.08% +84.13% +180.21 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for STAB.